Chanda Sanjay
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Chanda Sanjay. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ANTX | Chief Development Officer | Award / Grant | 50,250 | — | — | Feb 26, 2025 |
| ANTX | Chief Development Officer | Sale | 2,957 | $1.34 | $3,962 | Jan 3, 2025 |
| ANTX | Chief Development Officer | Award / Grant | 27,500 | — | — | Mar 15, 2024 |
| ANTX | Chief Development Officer | Award / Grant | 27,500 | — | — | Mar 15, 2024 |
| 0001411158 | SVP, Drug Development | Option Exercise | 48 | $7.55 | $362 | Mar 4, 2015 |
| 0001411158 | SVP, Drug Development | Award / Grant | 5,020 | — | — | Feb 3, 2015 |
| 0001411158 | SVP, Drug Development | Option Exercise | 12,062 | $5.59 | $67,427 | Dec 19, 2014 |
| 0001411158 | SVP, Drug Development | Sale | 5,000 | $35.00 | $175,000 | Nov 26, 2014 |
| 0001411158 | SVP, Drug Development | Option Exercise | 4,953 | $5.00 | $24,765 | Sep 10, 2014 |